...NF1-associated pediatric low-grade gliomas. NF1 stands out as having a higher association with primary headache disorder...
...NF1 and inoperable PNs. Patients with NF1 and inoperable PNs aged ≥ 1 month to ≤ 25 years when starting trametinib were ...
...NF1. Original articles reporting the efficacy and safety of selumetinib in patients with NF1 were identified in PubMed a...
...NF1) cases. The dystrophic type of NF1 progresses rapidly and can cause severe neurological complications if left untrea...
...NF1) using a three-dimensional (3D) segmentation and computerized volumetry technique, and to compare PET WB-MTV between...
...NF1). PNs that cause airway compromise or pulmonary dysfunction are uncommon but clinically important. Because improveme...
...NF1), 8 years after initial resection of primary bilateral adrenal pheochromocytomas without metastases. A 44-year-old w...
...NF1) and examine associations with demographic, disease-related and anthropomorphic features.,A consecutive series of pa...
...NF1, and TP53(x2) genes and 30 variants of unknown significance (VOUS) in ABL1, ASXL1, ATM, BCOR, BCORL1, BRNIP3, CDH2, ...
Selumetinib is approved for the treatment of pediatric patients with neurofibromatosis type 1 (NF1) who have symptomatic...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
